A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants
Clinical trial NCT02515955 · COMPLETED
Trial details
- NCT number
- NCT02515955
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.